- Home
- CDXS vs ELMD Comparison
CDXS vs ELMD Comparison
Compare CDXS & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- ELMD
- Stock Information
- Founded
- CDXS 2002
- ELMD 1992
- Country
- CDXS United States
- ELMD United States
- Employees
- CDXS N/A
- ELMD N/A
- Industry
- CDXS Major Chemicals
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CDXS Industrials
- ELMD Health Care
- Exchange
- CDXS Nasdaq
- ELMD Nasdaq
- Market Cap
- CDXS 216.6M
- ELMD 206.6M
- IPO Year
- CDXS 2010
- ELMD 2010
- Fundamental
- Price
- CDXS $2.65
- ELMD $24.18
- Analyst Decision
- CDXS Buy
- ELMD Strong Buy
- Analyst Count
- CDXS 2
- ELMD 2
- Target Price
- CDXS $11.00
- ELMD $35.50
- AVG Volume (30 Days)
- CDXS 542.5K
- ELMD 45.1K
- Earning Date
- CDXS 10-30-2025
- ELMD 11-11-2025
- Dividend Yield
- CDXS N/A
- ELMD N/A
- EPS Growth
- CDXS N/A
- ELMD 46.55
- EPS
- CDXS N/A
- ELMD 0.85
- Revenue
- CDXS $57,164,000.00
- ELMD $64,000,000.00
- Revenue This Year
- CDXS $12.88
- ELMD $14.47
- Revenue Next Year
- CDXS $21.64
- ELMD $10.33
- P/E Ratio
- CDXS N/A
- ELMD $28.56
- Revenue Growth
- CDXS N/A
- ELMD 16.97
- 52 Week Low
- CDXS $1.90
- ELMD $17.73
- 52 Week High
- CDXS $6.08
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- CDXS 55.26
- ELMD 49.28
- Support Level
- CDXS $2.46
- ELMD $23.92
- Resistance Level
- CDXS $2.76
- ELMD $25.05
- Average True Range (ATR)
- CDXS 0.16
- ELMD 0.80
- MACD
- CDXS 0.02
- ELMD -0.16
- Stochastic Oscillator
- CDXS 50.97
- ELMD 16.19
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.